Continuous ambulatory peritoneal dialysis (CAPD) treatment is the first continuously working detoxification procedure applied to uremic patients. However, the uninterrupted exposure of artificial fluids to the organism is accompanied by some side effects among which the continuous absorption of D-glucose from the dialysate is unequivocal: Figures presented in available literature report from approximately 50 to 200g per day [1–3]. Excess energy uptake is currently regarded to be one major risk factor for the development of atherosclerosis and diabetes mellitus. The continuing absorption of large amounts of D-glucose from the dialysate therefore would add to the already enlarged cardiovascular risk of patients on maintenance dialysis. Howeve...
Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.BackgroundThe feas...
Introduction: Diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) are more prone t...
Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. During a 10 y...
Continuous ambulatory peritoneal dialysis (CAPD) treatment is the first continuously working detoxif...
The majority of peritoneal dialysates contain glucose, which can potentially be absorbed from the pe...
Glucose absorption during continuous ambulatory peritoneal dialysis. Patients undergoing continuous ...
Energy and protein metabolism are both altered in chronic kidney disease (CKD) from its early stages...
INTRODUCTION AND AIMS: Peritoneal dialysis (PD) solutions using glucose as osmotic agent have been u...
The stabilization of systemic blood pressure is one of the most challenging tasks in the management ...
Background: For patients on peritoneal dialysis (PD), the deleterious effects of high concentration...
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS).I...
Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysi...
Diabetic nephropathy is becoming a major and growing cause of endstage renal disease (ESRD) in all i...
Glucose oxidation after a peritoneal and an oral glucose load in dialyzed patients. Glucose oxidatio...
textabstractUp to 50% of uremic patients, including those treated with peritoneal dialysis (PD), s...
Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.BackgroundThe feas...
Introduction: Diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) are more prone t...
Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. During a 10 y...
Continuous ambulatory peritoneal dialysis (CAPD) treatment is the first continuously working detoxif...
The majority of peritoneal dialysates contain glucose, which can potentially be absorbed from the pe...
Glucose absorption during continuous ambulatory peritoneal dialysis. Patients undergoing continuous ...
Energy and protein metabolism are both altered in chronic kidney disease (CKD) from its early stages...
INTRODUCTION AND AIMS: Peritoneal dialysis (PD) solutions using glucose as osmotic agent have been u...
The stabilization of systemic blood pressure is one of the most challenging tasks in the management ...
Background: For patients on peritoneal dialysis (PD), the deleterious effects of high concentration...
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS).I...
Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysi...
Diabetic nephropathy is becoming a major and growing cause of endstage renal disease (ESRD) in all i...
Glucose oxidation after a peritoneal and an oral glucose load in dialyzed patients. Glucose oxidatio...
textabstractUp to 50% of uremic patients, including those treated with peritoneal dialysis (PD), s...
Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.BackgroundThe feas...
Introduction: Diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) are more prone t...
Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. During a 10 y...